Sulfation is required for bone morphogenetic protein 2-dependent Id1 induction

Biochemical and Biophysical Research Communications

Volumn 344, Issue 4, 2006, Pages 1207-1215

  Osses, Nelson ^a,b   Gutierrez, Jaime ^b   Lopez Rovira, Teresa ^a   Ventura, Francesc ^a   Brandan, Enrique ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Unidad de Reproduccion y Desarrollo   (Chile)

Author keywords

BMP 2; Id1; Muscle cells; Proteoglycans; Sulfation inhibitor

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; GLYCOSAMINOGLYCAN; INHIBITOR OF DIFFERENTIATION 1; LYASE; PROTEOGLYCAN; SODIUM CHLORATE;

ANIMAL CELL; ARTICLE; CELL LINE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN ISOLATION; PROTEIN SYNTHESIS INHIBITION; SULFATION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; CHLORATES; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICE; MULTIENZYME COMPLEXES; SULFATE ADENYLYLTRANSFERASE; SULFATES; TRANSFORMING GROWTH FACTOR BETA;

EID: 33646481319     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.029     Document Type: Article

References (38)

1. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., and Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science 242 (1988) 1528-1534
2. Wan M., and Cao X. BMP signaling in skeletal development. Biochem. Biophys. Res. Commun. 328 (2005) 651-657
3. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., and Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell. Biol. 127 (1994) 1755-1766
4. Takada T., Katagiri T., Ifuku M., Morimura N., Kobayashi M., Hasegawa K., Ogamo A., and Kamijo R. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J. Biol. Chem. 278 (2003) 43229-43235
5. Nohe A., Keating E., Knaus P., and Petersen N.O. Signal transduction of bone morphogenetic protein receptors. Cell. Signal. 16 (2004) 291-299
6. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
7. Lopez-Rovira T., Chalaux E., Massague J., Rosa J.L., and Ventura F. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 277 (2002) 3176-3185
8. Vinals F., and Ventura F. Myogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1. J. Biol. Chem. 279 (2004) 45766-45772
9. Nakashima K., Takizawa T., Ochiai W., Yanagisawa M., Hisatsune T., Nakafuku M., Miyazono K., Kishimoto T., Kageyama R., and Taga T. BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc. Natl. Acad. Sci. USA 98 (2001) 5868-5873
10. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., and Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68 (1999) 729-777
11. Larrain J., Carey D.J., and Brandan E. Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism. J. Biol. Chem. 273 (1998) 32288-32296
12. Fuentealba L., Carey D.J., and Brandan E. Antisense inhibition of syndecan-3 expression during skeletal muscle differentiation accelerates myogenesis through a basic fibroblast growth factor-dependent mechanism. J. Biol. Chem. 274 (1999) 37876-37884
13. Riquelme C., Larrain J., Schonherr E., Henriquez J.P., Kresse H., and Brandan E. Antisense inhibition of decorin expression in myoblasts decreases cell responsiveness to transforming growth factor beta and accelerates skeletal muscle differentiation. J. Biol. Chem. 276 (2001) 3589-3596
14. Wang E.A., Rosen V., D'Alessandro J.S., Bauduy M., Cordes P., Harada T., Israel D.I., Hewick R.M., Kerns K.M., LaPan P., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. USA 87 (1990) 2220-2224
15. Sampath T.K., Muthukumaran N., and Reddi A.H. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc. Natl. Acad. Sci. USA 84 (1987) 7109-7113
16. Irie A., Habuchi H., Kimata K., and Sanai Y. Heparan sulfate is required for bone morphogenetic protein-7 signaling. Biochem. Biophys. Res. Commun. 308 (2003) 858-865
17. Baeuerle P.A., and Huttner W.B. Chlorate-a potent inhibitor of protein sulfation in intact cells. Biochem. Biophys. Res. Commun. 141 (1986) 870-877
18. Deprez P., Doss-Pepe E., Brodsky B., and Inestrosa N.C. Interaction of the collagen-like tail of asymmetric acetylcholinesterase with heparin depends on triple-helical conformation, sequence and stability. Biochem. J. 350 Pt. 1 (2000) 283-290
19. Lopez-Casillas F., Wrana J.L., and Massague J. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73 (1993) 1435-1444
20. Osses N., and Brandan E. ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. Am. J. Physiol. Cell Physiol. 282 (2002) C383-C394
21. Humphries D.E., and Silbert J.E. Chlorate: a reversible inhibitor of proteoglycan sulfation. Biochem. Biophys. Res. Commun. 154 (1988) 365-371
22. Melo F., Carey D.J., and Brandan E. Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression. J. Cell. Biochem. 62 (1996) 227-239
23. Larrain J., Cizmeci-Smith G., Troncoso V., Stahl R.C., Carey D.J., and Brandan E. Syndecan-1 expression is down-regulated during myoblast terminal differentiation. Modulation by growth factors and retinoic acid. J. Biol. Chem. 272 (1997) 18418-18424
24. Larrain J., Alvarez J., Hassell J.R., and Brandan E. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation. Exp. Cell Res. 234 (1997) 405-412
25. Brandan E., Carey D.J., Larrain J., Melo F., and Campos A. Synthesis and processing of glypican during differentiation of skeletal muscle cells. Eur. J. Cell Biol. 71 (1996) 170-176
26. Gutierrez J., Osses N., and Brandan E. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2. J. Cell. Physiol. 206 (2006) 58-67
27. Chen X.D., Fisher L.W., Robey P.G., and Young M.F. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J. 18 (2004) 948-958
28. Hamati H.F., Britton E.L., and Carey D.J. Inhibition of proteoglycan synthesis alters extracellular matrix deposition, proliferation, and cytoskeletal organization of rat aortic smooth muscle cells in culture. J. Cell. Biol. 108 (1989) 2495-2505
29. Chalaux E., Lopez-Rovira T., Rosa J.L., Bartrons R., and Ventura F. JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2. J. Biol. Chem. 273 (1998) 537-543
30. Yamamoto N., Akiyama S., Katagiri T., Namiki M., Kurokawa T., and Suda T. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem. Biophys. Res. Commun. 238 (1997) 574-580
31. Bansal R., and Pfeiffer S.E. Inhibition of protein and lipid sulfation in oligodendrocytes blocks biological responses to FGF-2 and retards cytoarchitectural maturation, but not developmental lineage progression. Dev. Biol. 162 (1994) 511-524
32. Delehedde M., Seve M., Sergeant N., Wartelle I., Lyon M., Rudland P.S., and Fernig D.G. Fibroblast growth factor-2 stimulation of p42/44 MAPK phosphorylation and IkappaB degradation is regulated by heparan sulfate/heparin in rat mammary fibroblasts. J. Biol. Chem. 275 (2000) 33905-33910
33. Cho Y.R., Lee S.J., Jeon H.B., Park Z.Y., Chun J.S., and Yoo Y.J. Under-sulfation by PAPS synthetase inhibition modulates the expression of ECM molecules during chondrogenesis. Biochem. Biophys. Res. Commun. 323 (2004) 769-775
34. Nohe A., Hassel S., Ehrlich M., Neubauer F., Sebald W., Henis Y.I., and Knaus P. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem. 277 (2002) 5330-5338
35. Ibrahimi O.A., Zhang F., Hrstka S.C., Mohammadi M., and Linhardt R.J. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry 43 (2004) 4724-4730
36. Ruppert R., Hoffmann E., and Sebald W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 237 (1996) 295-302
37. Ohkawara B., Iemura S., ten Dijke P., and Ueno N. Action range of BMP is defined by its N-terminal basic amino acid core. Curr. Biol. 12 (2002) 205-209
38. Lopez-Rovira T., Chalaux E., Rosa J.L., Bartrons R., and Ventura F. Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter. J. Biol. Chem. 275 (2000) 28937-28946